Levocetirizina Tarbis (Levocetirizine Dihydrochloride)

Levocetirizine works by selectively binding to peripheral histamine H1 receptors, preventing histamine from triggering the cascade that leads to vasodilation, increased vascular permeability, and nerve stimulation. This blockade reduces the classic allergic signs of itching, swelling, and mucus production without significant penetration of the central nervous system.

The exact dose is determined by the prescribing healthcare professional based on the patient’s age, renal function, and clinical response. In most adult cases, a single daily dose is typical, but the prescriber will set the appropriate strength and frequency for each individual.

Levocetirizine is classified as pregnancy category B, indicating that animal studies have not shown risk and there are no adequate human studies. It may be used during pregnancy only if the potential benefit justifies the potential risk. Limited data suggest it is compatible with breastfeeding, but a clinician should evaluate each case.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levocetirizine is the active enantiomer of cetirizine, offering higher affinity for the H1 receptor and a lower incidence of central nervous system sedation compared with first‑generation antihistamines. Compared with other second‑generation agents, its efficacy in controlling urticaria is comparable, while its rapid onset and once‑daily dosing are advantageous.

The product should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. No refrigeration is required for this oral tablet formulation.

Levocetirizina Tarbis is taken orally, usually with a glass of water. It can be taken with or without food, and patients should follow the dosing instructions provided by their healthcare professional. Swallow the tablet whole; do not crush or chew unless specifically instructed.

Serious adverse reactions, although rare, include angioedema (swelling of the face, lips, tongue), anaphylactic reactions, and severe skin conditions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. Patients should seek immediate medical attention if they experience rapid swelling, difficulty breathing, or widespread rash.

Levocetirizina Tarbis should be avoided in individuals with known hypersensitivity to levocetirizine or any excipients in the tablet. It is also contraindicated in patients with severe renal impairment unless dose adjustment is made, and it should be used with caution in children under the age for which safety has not been established.